Restricted accessResearch articleFirst published online 2022-12
Experiences with an Addiction Consultation Service on Care Provided to Hospitalized Patients with Opioid use Disorder: A Qualitative Study of Hospitalists,Nurses,Pharmacists,and Social Workers
In response to the opioid epidemic, addiction consultation services (ACS) increasingly provide dedicated hospital-based addiction treatment to patients with substance use disorder. We assessed hospitalist and medical staff perceptions of how the presence of 2 hospitals’ ACS impacted care for hospitalized patients with opioid use disorder (OUD). We inquired about ongoing challenges in caring for this patient population.
Methods
We conducted a qualitative study of hospital-based providers utilizing focus groups and key informant interviews for data collection. Transcripts were analyzed using a mixed inductive-deductive approach. Emergent themes were identified through an iterative, multidisciplinary team–based process using a directed content analysis approach.
Results
Hospitalists (n = 20), nurses (n = 13), social workers (n = 11), and pharmacists (n = 18) from a university hospital and a safety-net hospital in Colorado participated in focus groups or key informant interviews. In response to the availability of an ACS, hospitalists described increased confidence using methadone and buprenorphine to treat opioid withdrawal, which they perceived as contributing to improved patient outcomes and greater job satisfaction. Participants expressed concern about inconsistent care provided to patients with OUD that varied by the admitting team's specialty and the physician's background and training. Nurses and hospitalists reported frustrations with achieving adequate pain control among patients with OUD. Last, pharmacists reported practice variations when physicians dosed buprenorphine for acute pain among patients with OUD. A lack of standardized dosing led to concerns of inadequate analgesia or return to opioid use following hospital discharge.
Conclusions
An ACS reportedly supports hospitalists and medical staff to best care for hospitalized patients with OUD. Notably, care provided to patients with OUD may not be uniform depending on various physician-level factors. Future work to address the concerns reported by study participants may include education for OUD treatment, early involvement of the ACS, and incorporation of buprenorphine prescribing algorithms to standardize care.
RudasillSE, SanaihaY, MardockALClinical outcomes of infective endocarditis in injection drug users. J Am Coll Cardiol. 2019;73(5):559–570.
2.
WeissAJ, ElixhauserA, BarrettML, SteinerCA, BaileyMK, O'MalleyL.Opioid-related inpatient stays and emergency department visits by state, 2009–2014: statistical brief #219. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006.
3.
SinghJA, ClevelandJD.National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality. PLoS One. 2020;15(2):e0229174.
4.
ChoiM, KimH, QianH, PalepuA.Readmission rates of patients discharged against medical advice: a matched cohort study. PLoS One. 2011;6(9):e24459.
5.
Mejia de GrubbMC, SalemiJL, GonzalezSJ, ChimaCC, KowalchukAA, ZoorobRJ.Opioid, cocaine, and amphetamine use disorders are associated with higher30-day inpatient readmission rates in the United States. Subst Abus. 2020;41(3):310–365.
6.
SordoL, BarrioG, BravoMJMortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.
7.
HickmanM, SteerC, TillingKThe impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom. Addiction. 2018;113(8):1461–1476.
8.
MattickRP, BreenC, KimberJ, DavoliM.Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2003;(2):CD002209.
9.
NoskaA, MohanA, WakemanS, RichJ, BoutwellA.Managing opioid use disorder during and after acute hospitalization: a case-based review clarifying methadone regulation for acute care settings. J Addict Behav Ther Rehabil. 2015;4(2):1000138.
10.
US Department of Justice DEA, Diversion Control Divsion. Title 21 Code of Federal Regulations: PART 1306 — PRESCRIPTIONS: §1306.07 Administering or dispensing of narcotic drugs. DRUG ENFORCEMENT ADMINISTRATION. https://www.deadiversion.usdoj.gov/21cfr/cfr/1306/1306_07.htm. Published 2020. Accessed May 19, 2021.
11.
RosenthalES, KarchmerAW, Theisen-ToupalJ, CastilloRA, RowleyCF.Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis. Am J Med. 2016;129(5):481–485.
12.
PetersonC, XuL, MikoszCA, FlorenceC, MackKA. US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011–2015. J Subst Abuse Treat. 2018;92:35–39.
13.
KilaruAS, XiongA, LowensteinMIncidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Netw Open. 2020;3(5):e205852.
14.
LarochelleMR, BernsonD, LandTMedication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137–145.
15.
CalcaterraSL, McBethL, KenistonAM, BurdenM.The development and implementation of a hospitalist-directed addiction medicine consultation service to address a treatment gap. J Gen Intern Med. 2021. doi:10.1007/s11606-021-06849-8
16.
BraithwaiteV, TiL, FairbairnN,et al. Building a hospital-based addiction medicine consultation service in Vancouver, Canada: the path taken and lessons learned. Addiction. 2021;116(7):1892–1900.
17.
WeinsteinZM, WakemanSE, NolanS.Inpatient addiction consult service: expertise for hospitalized patients with complex addiction problems. Med Clin North Am. 2018;102(4):587–601.
18.
EnglanderH, DobbertinK, LindBKInpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34(12):2796–2803.
19.
WakemanSE, KaneM, PowellE, HowardS, ShawC, ReganS.Impact of inpatient addiction consultation on hospital readmission. J Gen Intern Med. 2021;36(7):2161–2163.
20.
WakemanSE, MetlayJP, ChangY, HermanGE, RigottiNA.Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity. J Gen Intern Med. 2017;32(8):909–916.
PriestKC, McCartyD.The role of the hospital in the 21st century opioid overdose epidemic: the addiction medicine consult service. J Addict Med. 2019;13(2):104–112.
23.
EnglanderH, CollinsD, PerrySP, RabinowitzM, PhoutridesE, NicolaidisC. “We've learned it's a medical illness, not a moral choice”: qualitative study of the effects of a multicomponent addiction intervention on hospital providers'attitudes and experiences. J Hosp Med. 2018;13(11):752–758.
24.
CalcaterraSL, BinswangerIA, EdelmanEJ, McNairBK, WakemanSE, O'ConnorPG.The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: A survey of hospitalist physicians. Subst Abus. 2020:1–9. doi:10.1080/08897077.2020.1748169
25.
WakemanSE, KanterGP, DonelanK.Institutional substance use disorder intervention improves general internist preparedness, attitudes, and clinical practice. J Addict Med. 2017;11(4):308–314.
26.
CollinsD, AllaJ, NicolaidisC “If it wasn't for him, I wouldn't have talked to them”: qualitative study of addiction peer mentorship in the hospital. J Gen Intern Med. 2019. doi:10.1007/s11606-019-05311-0
27.
DenzinNK, LincolnYS.Introduction: The discipline and practice of qualitative research. In: DenzinNK, LincolnYS, eds. The Sage Handbook of Qualitative Research. Thousand Oaks, CA: Sage Publications Ltd.; 2005:1–32.
28.
CreswellJW, PothCN.Qualitative Inquiry and Research Design: Choosing among Five Approaches. Thousand Oaks, CA: Sage publications; 2016.
29.
StarksH, Brown TrinidadS.Choose your method: A comparison of phenomenology, discourse analysis, and grounded theory. Qual Health Res. 2007;17(10):1372–1380.
30.
SchliepME, AlonzoCN, MorrisMA.Beyond RCTs: innovations in research design and methods to advance implementation science. Evid-Based Commun Assess Intervent. 2017;11(3–4):82–98.
31.
FettersMD.The Mixed Methods Research Workbook: Activities for Designing, Implementing, and Publishing Projects. Thousand Oaks, CA: SAGE Publications; 2019.
32.
GuestG, BunceA, JohnsonL.How many interviews are enough?: An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.
33.
MorganDL.Focus Groups as Qualitative Research. Vol 16. Thousand Oaks, CA: Sage publications; 1996.
34.
RonanMV, HerzigSJ.Hospitalizations related to opioid abuse/dependence and associated serious infections increased sharply, 2002–12. Health Aff (Millwood)). 2016;35(5):832–837.
35.
CabanaMD, RandCS, PoweNR “Why don't physician follow clinical practice guidelines?” A framework for improvement. JAMA. 1999;282(15):1458–1465.
36.
DonabedianA.Evaluating the quality of medical care. Milbank Q. 2005;83(4):691–729.
37.
WakemanSE, Pham-KanterG, DonelanK.Attitudes, practices, and preparedness to care for patients with substance use disorder: results from a survey of general internists. Subst Abus. 2016;37(4):635–641.
38.
TongA, SainsburyP, CraigJ.Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357.
39.
Analysis AtQD. Qualitative Data Analysis Software. https://atlasti.com/. Published 2020. Accessed February 13, 2021.
40.
HsiehH-F, ShannonSE.Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–1288.
41.
DonabedianA.Evaluating the quality of medical care. Milbank Mem Fund Q. 1966;44(3): 166–206.
42.
FeredayJ, Muir-CochraneE.Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Int J Qual Methods. 2006;5(1):80–92.
43.
Department of Veterans Affairs. VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders. Washington, DC: Department of Veterans Affair–Department of Defense United States of America; 2015.
44.
GowingL, AliR, DunlopA, FarrellM, LintzerisN.National guidelines for medication-assisted treatment of opioid dependence. Canberra: Commonwealth of Australia; 2014:77–162.
45.
BruneauJ, AhamadK, GoyerMEManagement of opioid use disorders: a national clinical practice guideline. CMAJ. 2018;190(9):E247–E257.
46.
CunninghamCE, FishmanM, GordonAJThe ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update. J Addict Med. 2020;14(2S Suppl 1):1–91.
MattickRP, BreenC, KimberJ, DavoliM.Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Syst Rev. 2009;(3):CD002209. doi:10.1002/14651858.CD002209.pub2
49.
MattickRP, BreenC, KimberJ, DavoliM.Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;(2). doi: 10.1002/14651858.CD002207.pub2
50.
GowingL, AliR, WhiteJM.Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev. 2009;(3):CD002025. doi:10.1002/14651858.CD002025.pub5
Substance Abuse and Mental Health Services Administration. Federal Guidelines for Opioid Treatment Programs. HHS Publication No. (SMA) XX-XXXX. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015.
55.
TiL, VoonP, DobrerS, MontanerJ, WoodE, KerrT.Denial of pain medication by health care providers predicts in-hospital illicit drug use among individuals who use illicit drugs. Pain Res Manag. 2015;20(2):84–88.
56.
AlfordDP, ComptonP, SametJH.Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144(2):127–134.
57.
GoelA, AzargiveS, WeissmanJSPerioperative Pain and Addiction Interdisciplinary Network (PAIN) clinical practice advisory for perioperative management of buprenorphine: results of a modified Delphi process. Br J Anaesth. 2019;123(2):e333–e342.
58.
HaberLA, DeFriesT, MartinM.Things we do for no reason™: Discontinuing buprenorphine when treating acute pain. J Hosp Med. 2019;14(10):633–635.
59.
LembkeA, OttestadE, SchmiesingC.Patients maintained on buprenorphine for opioid use disorder should continue buprenorphine through the perioperative period. Oxford University Press; 2019.
60.
QuayeAN-A, ZhangY.Perioperative management of buprenorphine: solving the conundrum. Pain Med. 2019;20(7):1395–1408.
61.
QuayeA, PotterK, RothS, AcamporaG, MaoJ, ZhangY. Perioperative continuation of buprenorphine at low-moderate doses was associated with lower postoperative pain scores and decreased outpatient opioid dispensing compared with buprenorphine discontinuation. Pain Med. 2020;21(9):1955–1960.
62.
GoelA, AzargiveS, LambaWThe perioperative patient on buprenorphine: a systematic review of perioperative management strategies and patient outcomes. Can J Anesth/J Can Anesth. 2019;66(2):201–217.
63.
ButowP, SharpeL.The impact of communication on adherence in pain management. PAIN®. 2013;154 Suppl 1:S101–S107.
64.
MillardL, HallettC, LukerK. Nurse-patient interaction and decision-making in care: patient involvement in community nursing. J Adv Nurs. 2006;55(2):142–150.
65.
CormieP, NairnM, WelshJ.Control of pain in adults with cancer: summary of SIGN guidelines. BMJ. 2008;337:a2154.
66.
HoltropJS, FisherM, MartinezDEWhat works for managing chronic pain: an appreciative inquiry qualitative analysis. J Prim Care Community Health. 2019;10:2150132719885286.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
